Manatt Health Solutions
Download Contact (.vcf)
San Francisco Direct: 415.291.7402 General: 415.291.7400 Fax: 415.291.7474
of North Carolina, Gillings School
of Global Public Health, Dr.P.H., 2011.
Columbia University, Mailman School of Public Health, M.P.H., 2008.
Hamline University, School of Law, J.D., 1995.
University of California, Davis, B.A., English, 1991.
Nancy McGee is a managing director of Manatt Health Solutions,
an interdisciplinary policy and business advisory practice of
Manatt, Phelps & Phillips, LLP. With over 18 years of
experience advising pharmaceutical, biotechnology and medical
device companies, Dr. McGee is widely known for her expertise in
reimbursement issues, particularly helping clients create effective
coverage and payment strategies and developing new offerings
designed to address payer and patient access issues. She
works with life sciences companies to identify opportunities and
develop creative strategic and tactical approaches for specific
products by analyzing healthcare policy, industry and distribution
trends.Prior to joining Manatt, Dr. McGee was Senior Vice President and
Chief Operating Officer for Lash Group (AmerisourceBergen
Corporation). In that role, she was an operational leader
with P/L responsibility for an extensive portfolio of patient
management programs and projects to help patients access new
therapies. She led over 100 pharmaceutical, biotechnology and
medical device manufacturer-sponsored patient access programs
representing several hundred products.
Dr. McGee's project management and international consulting
experience includes advising product manufacturers, payers,
physician specialty societies and industry thought leaders across a
range of coverage, payment, and distribution issues. She
leads specialized advisory boards for clients and conducts
management and field force training sessions. In addition,
she designs specialized programs to assist physicians, patients and
caregivers in navigating the complexities of the insurance
industry. Dr. McGee is a frequent lecturer on trends in
healthcare legislation and the insurance industry in the United
States and overseas.
Before joining Lash Group, Dr. McGee was Vice President of
Reimbursement for The Lewin Group, where she led both the
reimbursement strategic consulting practice and the reimbursement
support service lines. She previously served as Director,
Legal Affairs & Reimbursement at Somnus Medical Technologies,
Inc., and as corporate counsel with VidaMed, Inc.
“How Pharmaceutical Manufacturers Are Planning
for Coverage Expansion in 2014,” Health Policy and Management Healthcare
Conference, Columbia University, Mailman School of Public Health, New York, New
York, April 13, 2013.
“Health Technology Assessment Evidence Criteria
for Screening Products,” International Society for Pharmaeconomics and Outcomes
Research (ISPOR) 15th Annual European Congress, Berlin, Germany, November 2012. “Adherence and Compliance Services in the U.S.,” GIRP: The European Association of Pharmaceutical
Wholesalers Autumn Conference, Brussels,
November 2012. “Health Technology Assessment Evidence
Criteria: What Types of Evidence Should Be Presented for Products Used to
Screen for Disease in the United States?” Health Technology Assessment
International (HTAi) Annual Meeting, Bilbao, Spain, June 25-27, 2012.
“Health Care Reform and Its Impact on Patient
Assistance Programs,” 7th Annual 340B Conference Sponsored by Safety Net
Hospitals for Pharmaceutical Access, February 9, 2011.
“Patient Assistance Programs in the New
Decade: Analysis and Best Practices for Pharmaceutical Manufacturers,”
AmerisourceBergen Knowledge-Driven Webisode, March 17, 2010.
“Developing U.S. Reimbursement Strategies for
Conventional and Combination Medical Devices,” University of California,
Berkeley, Extension Education Program, November 10, 2006.
© 2013 Manatt, Phelps & Phillips, LLP. All rights reserved.